Bilateral subdural hematoma following implantation of intrathecal drug delivery device

Neuromodulation. 2011 Mar-Apr;14(2):179-81; discussion 182. doi: 10.1111/j.1525-1403.2011.00335.x. Epub 2011 Mar 1.

Abstract

Objectives: To report a case of bilateral subacute subdural hematoma following implantation of intrathecal drug delivery device.

Materials and methods: We present here the case of a 41-year-old woman with multiple sclerosis and intractable spasticity who developed a bilateral subacute subdural hematoma after the placement of an intrathecal catheter connected to a programmable pump for baclofen infusion.

Results: Surgical drainage of the hematoma resulted in full neurologic recovery. This complication due to intracranial hypotension following lumbar puncture has been previously reported only once in patients with implanted intrathecal drug delivery device.

Conclusions: Medical and nursing staff dealing with intrathecal therapy should be aware of this potentially severe complication.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Baclofen / administration & dosage*
  • Baclofen / therapeutic use
  • Female
  • Hematoma, Subdural / etiology*
  • Hematoma, Subdural / surgery
  • Humans
  • Infusion Pumps, Implantable / adverse effects*
  • Injections, Spinal / adverse effects*
  • Multiple Sclerosis / complications
  • Multiple Sclerosis / drug therapy
  • Muscle Relaxants, Central / administration & dosage*
  • Muscle Relaxants, Central / therapeutic use
  • Muscle Spasticity / drug therapy
  • Muscle Spasticity / etiology
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Muscle Relaxants, Central
  • Baclofen